Results 181 to 190 of about 711,939 (323)
Targeted FABP5 co‐delivery nanoparticles amplify RFA‐induced ferroptosis and intratumoral immune rewiring via STING/TBK1 pathway activation in HCC. The pH‐responsive lipid nanoshell was integrated with cyclic RGD peptide (cRGD) and red blood cell membrane (RBCM), and encapsulated with superparamagnetic iron oxide (SPIO) and sgFABP5 to construct FS@RBCM/
Bufu Tang +16 more
wiley +1 more source
NLR Risk Score for Predicting Patient Prognosis in Hepatocellular Carcinoma and Identification of Oncogenic Role of NLRP5 in Hepatocellular Carcinoma. [PDF]
Tang M +14 more
europepmc +1 more source
Ultrastructure of Human Hepatocellular Carcinoma-Fine Structure of Blood Spaces (Tumor Vessels)
Tadashi Isomura
openalex +2 more sources
Clustering of Hepatitis B virus Infection and Hepatocellular Carcinoma in a Family1 [PDF]
I T Gilmore +2 more
openalex +1 more source
This work constructs magnetic nanoparticles (MNPs) and incorporates them with silver rods coated with 125I to form a novel composite seed, which exhibits direction‐independent and self‐regulated heating efficiency, as well as the capacity of preventing MNPs leakage and enabling repeated hyperthermia.
Bin Xu +22 more
wiley +1 more source
Hepatocellular carcinoma in chinese males and females. Possible causes for the male predominance [PDF]
Ching–Lung Lai +5 more
openalex +1 more source
Inhibition of Tumor Lipogenesis and Growth by Peptide‐Based Targeting of SREBP Activation
A peptide that replicates the amino acid sequence in Insig1/2 loop 1 inhibits the IGF1‐induced interaction between PCK1 and Insig1/2, PCK1‐mediated phosphorylation of Insig1/2, and SREBP activity‐dependent lipid synthesis. Administration of the LNP‐Insig1/2 loop 1 peptide effectively attenuates tumor growth and sensitizes tumors to the antitumor effect
Shudi Luo +10 more
wiley +1 more source
Spectrum of therapeutic options in hepatocellular carcinoma. [PDF]
Shin HP, Lee M, Jeon JW.
europepmc +1 more source

